Hos patienter der fik en kombination af Herceptin og paclitaxel var der en stigning i den hæmatologiske toksicitet WHO grad 3 eller 4 sammenlignet med patienter som fik paclitaxel alene (34% versus 21%).
There was an increase in WHO Grade 3 or 4 haematological toxicity in patients treated with the combination of Herceptin and paclitaxel compared with patients receiving paclitaxel alone (34% versus 21%).